Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Immunodeficiency secondary to chemotherapy |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
mucite à la suite d'une chimiothérapie |
Is a |
False |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Post-chemotherapy testicular hypofunction |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Post-chemotherapy ovarian failure |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
nausées et vomissements provoqués par la chimiothérapie |
Is a |
False |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
neutropénie provoquée par une chimiothérapie |
Is a |
False |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Inflammation of esophagus due to chemotherapy (disorder) |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Peripheral neuropathy due to chemotherapy |
Is a |
False |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Azoospermia caused by chemotherapy (disorder) |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Therapy related acute myeloid leukaemia due to and following administration of antineoplastic agent |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbour unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain). |
Is a |
False |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving the mixed lineage leukaemia gene at 11q23. This subgroup of t-MN is typically associated with overt leukaemia, without preceding myelodysplastic syndrome, developing 2-3 years after exposure, presenting with non-specific symptoms related to ineffective haematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement. |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Anemia due to and following chemotherapy |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Neutropaenia due to and following chemotherapy |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Peripheral neuropathy due to and following antineoplastic therapy (disorder) |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Cytotoxic drug-induced hypospermatogenesis |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Cutaneous ulceration due to cytotoxic therapy (disorder) |
Is a |
False |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Methotrexate skin ulceration (disorder) |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Dermatosis due to cytotoxic therapy (disorder) |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Agranulocytosis due to and following administration of antineoplastic agent (disorder) |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Nail dystrophy due to cytotoxic therapy (disorder) |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Chemotherapy-induced nausea and vomiting |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Chronic painful polyneuropathy following chemotherapy |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Disorder of spinal cord due to and following intrathecal injection of chemotherapeutic agent (disorder) |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Inflammation of mucous membrane due to and following chemotherapy |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Toxicity due to chemotherapy |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
A rare neoplastic disorder characterized by benign metastatic masses increasing in size and number after chemotherapy for non-seminomatous germ cell tumors of testis or ovary. It may present at any time after chemotherapy, with a median occurrence within 24 months after treatment completion. Per definition, the resected specimen exclusively contains mature teratoma components, and serum tumor markers have normalized. The retroperitoneum is the most common site, although almost any other localization has been reported. Increased tumor size may cause mechanical compression of vital organs, with renal dysfunction, bowel ischemia, and biliary obstruction as major complications. |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Stomatitis due to cytotoxic therapy (disorder) |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Thrombophilia due to antineoplastic agent therapy |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|
Heart failure following administration of antineoplastic agent |
Is a |
True |
Complication of chemotherapy (disorder) |
Inferred relationship |
Some |
|